Literature DB >> 6312337

Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.

D R Ferry, A Goll, H Glossmann.   

Abstract

Four 1,4-dihydropyridine calcium channel blockers [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110 (Isopropyl 4-(2,1,3,benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-methoxy- carbonylpyridine-3-carboxylate) were employed to label putative calcium channels in guinea-pig hind limb skeletal muscle membranes. The four radioligands differed with respect to the number of sites (Bmax) which were labelled. The following rank order of Bmax values was found: PN 200 110 greater than nimodipine = nitrendipine greater than nifedipine. d-cis-Diltiazem caused an increase in the density of high-affinity binding sites for all four calcium channel blockers. The relative stimulation was smallest for PN 200 110. It is suggested that 1,4-dihydropyridines exhibit different efficacies for induction of a channel state with high affinity for these drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312337     DOI: 10.1007/bf00497674

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle.

Authors:  N Himori; H Ono; N Taira
Journal:  Jpn J Pharmacol       Date:  1976-08

2.  Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.

Authors:  G Wiemer; A Wellstein; D Palm; H M von Hattingberg; D Brockmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

3.  [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.

Authors:  M Fosset; E Jaimovich; E Delpont; M Lazdunski
Journal:  Eur J Pharmacol       Date:  1982-12-17       Impact factor: 4.432

Review 4.  Ionic channels in skeletal muscle.

Authors:  E Stefani; D J Chiarandini
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

5.  Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding.

Authors:  H Glossmann; D R Ferry; C B Boschek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

6.  Identification of putative calcium channels in skeletal muscle microsomes.

Authors:  D R Ferry; H Glossmann
Journal:  FEBS Lett       Date:  1982-11-08       Impact factor: 4.124

7.  Dihydropyridines as potent calcium channel blockers in neuronal cells.

Authors:  M Takahashi; A Ogura
Journal:  FEBS Lett       Date:  1983-02-21       Impact factor: 4.124

8.  Maitotoxin, a Ca2+ channel activator candidate.

Authors:  M Takahashi; Y Ohizumi; T Yasumoto
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

9.  Slow inward calcium currents have no obvious role in muscle excitation-contraction coupling.

Authors:  H Gonzalez-Serratos; R Valle-Aguilera; D A Lathrop; M C Garcia
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

  9 in total
  14 in total

Review 1.  The molecular pharmacology and structural features of calcium channels.

Authors:  D R Ferry; A Goll; M Rombusch; H Glossmann
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

2.  Multiple voltage-sensitive calcium channels are probably involved in endogenous GABA release from striatal neurones differentiated in primary culture.

Authors:  J P Pin; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.

Authors:  A Goll; H Glossmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

4.  Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.

Authors:  W Ilias; K Steinbereithner
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  Calcium channels and intracellular calcium release are pharmacologically different in frog skeletal muscle.

Authors:  E W McCleskey
Journal:  J Physiol       Date:  1985-04       Impact factor: 5.182

6.  125I-iodipine, a new high affinity ligand for the putative calcium channel.

Authors:  D R Ferry; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

7.  Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.

Authors:  J Latifpour; M Yoshida; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

8.  Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry.

Authors:  S Batra
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

9.  The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain.

Authors:  P Supavilai; M Karobath
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

10.  Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.

Authors:  J Schwartz; J Velly
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.